Company intelligence / Profile preview

Alba Therapeutics

Baltimore, Maryland, United Statesbiospace.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 2

Overview

Alba Therapeutics developed therapeutics targeting the zonulin pathway to modulate tight junctions in epithelial barriers. Their lead programs focused on autoimmune and inflammatory diseases such as celiac disease. The company filed at least 35 patents related to autoimmune, gastrointestinal, and inflammatory disorders. Clinical results have not been recently published; historically their lead asset was evaluated in early-to-mid clinical trials for celiac disease.

Therapeutic areas: GastroenterologyEndocrinologyImmunology
Modalities: Small molecules (primary)potential for biologics and drug delivery technologies inferred from platform focus on tight junction modulation
Industry: Biotech

Drug pipeline

1 asset

AT-2490

Discontinued

Partnerships

Teva Pharmaceuticals/Cephalon collaboration agreement for development/commercialization of zonulin-based therapeutics.

Beyond the preview

Go deeper on Alba Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alba Therapeutics.

Explore the full profile